Ken Ebihara Selected Research

keishi-to

4/2017

Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ken Ebihara Research Topics

Disease

17	Obesity 10/2022 - 01/2002
15	Insulin Resistance 09/2020 - 01/2002
6	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 10/2022 - 05/2004
6	Body Weight (Weight, Body) 01/2020 - 12/2009
4	Fatty Liver 10/2022 - 11/2012
4	Insulinoma 05/2021 - 12/2005
4	Hypoglycemia (Reactive Hypoglycemia) 05/2021 - 09/2002
4	Hyperglycemia 09/2020 - 01/2005
4	Atherosclerosis 01/2020 - 01/2014
4	Lipodystrophy 06/2019 - 10/2012
3	Inflammation (Inflammations) 01/2020 - 05/2010
3	Autism Spectrum Disorder 05/2019 - 01/2017
3	Neoplasms (Cancer) 01/2014 - 02/2007
3	Lipoatrophic Diabetes Mellitus 12/2006 - 08/2004
2	Weight Loss (Weight Reduction) 09/2020 - 04/2010
2	Type 2 Diabetes Mellitus (MODY) 12/2016 - 10/2014
2	Familial Partial Lipodystrophy (Dunnigan Syndrome) 01/2014 - 12/2009
2	Glucagonoma 01/2013 - 12/2005
2	Diabetes Complications 09/2011 - 02/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011 - 02/2009
2	Hypertrophy 04/2010 - 01/2005
2	Hyperphagia (Overeating) 07/2009 - 02/2009
2	Diabetic Nephropathies (Diabetic Nephropathy) 02/2009 - 01/2005
2	Hypertension (High Blood Pressure) 02/2007 - 01/2002
1	Non-alcoholic Fatty Liver Disease 10/2022
1	Hyperaldosteronism (Conn Syndrome) 08/2022
1	Adenoma (Adenomas) 08/2022
1	Waardenburg Syndrome (Klein Syndrome) 04/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2021
1	Kallmann Syndrome (Kallmann's Syndrome) 04/2021
1	Anosmia 04/2021
1	Hypogonadism (Hypergonadotropic Hypogonadism) 04/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Disease Progression 01/2019
1	Autistic Disorder (Autism) 01/2019
1	Xanthomatosis (Xanthoma) 11/2018
1	Neurodevelopmental Disorders 04/2017
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Teratoma (Teratoid Tumor) 04/2016

Drug/Important Bio-Agent (IBA)

19	LeptinIBA 10/2022 - 01/2002
14	Glucose (Dextrose)FDA LinkGeneric 09/2020 - 01/2002
12	Insulin (Novolin)FDA Link 09/2020 - 01/2002
5	Triglycerides (Triacylglycerol)IBA 10/2014 - 02/2007
4	LipidsIBA 01/2020 - 08/2005
4	Hormones (Hormone)IBA 04/2012 - 01/2005
3	CholesterolIBA 01/2020 - 11/2018
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 12/2005
3	AMP-Activated Protein KinasesIBA 11/2012 - 02/2009
3	MelanocortinsIBA 07/2009 - 01/2002
2	Therapeutic UsesIBA 10/2022 - 11/2012
2	ThiazolidinedionesIBA 10/2022 - 12/2009
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2021
2	Nonsense Codon (Nonsense Mutation)IBA 04/2021 - 05/2004
2	Hypoglycemic Agents (Hypoglycemics)IBA 09/2020 - 04/2012
2	ipragliflozinIBA 09/2020 - 12/2016
2	Insulin ReceptorIBA 09/2020 - 06/2019
2	EnzymesIBA 01/2020 - 04/2010
2	kamisyoyo sanIBA 05/2019 - 01/2019
2	Pregnanolone (Allopregnanolone)IBA 01/2019 - 01/2017
2	CytokinesIBA 11/2018 - 11/2015
2	Pharmaceutical PreparationsIBA 04/2017 - 02/2009
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017 - 10/2016
2	Streptozocin (Streptozotocin)FDA Link 10/2014 - 02/2009
2	Messenger RNA (mRNA)IBA 01/2013 - 12/2005
2	Islet Amyloid PolypeptideIBA 04/2012 - 01/2011
2	AngiotensinogenIBA 09/2010 - 04/2010
2	GlucocorticoidsIBA 05/2010 - 05/2009
2	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 02/2009 - 01/2002
1	Rosiglitazone (Avandia)FDA Link 10/2022
1	AldosteroneIBA 08/2022
1	Sterol Regulatory Element Binding Protein 1IBA 01/2022
1	Octreotide (Sandostatin)FDA LinkGeneric 05/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2021
1	lanreotide (Somatuline)FDA Link 05/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Ketone BodiesIBA 01/2021
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 11/2020
1	Oxidoreductases (Dehydrogenase)IBA 11/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2020
1	Hemoglobins (Hemoglobin)IBA 09/2020
1	SodiumIBA 09/2020
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 05/2019
1	GlycolipidsIBA 01/2019
1	metreleptinIBA 01/2019
1	Leucine (L-Leucine)FDA Link 11/2018
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	Cholesterol Esters (Cholesteryl Esters)IBA 11/2018
1	Sterol O-AcyltransferaseIBA 11/2018
1	InflammasomesIBA 11/2018
1	keishi-toIBA 04/2017
1	Yi-Gan SanIBA 04/2017
1	Methylphenidate (Ritalin)FDA LinkGeneric 04/2017
1	Fenofibrate (CiL)FDA LinkGeneric 01/2017

Therapy/Procedure

8	Therapeutics 01/2019 - 08/2004
2	Gastrectomy 11/2015 - 01/2014
1	Kampo Medicine (Kampo) 04/2017
1	Glycemic Control 12/2016